ACOG News - Candlesense

Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences

VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a commercial-stage biopharmaceutical company dedicated to developing innovative treatments for neurodegen...

Investor relations

8 days ago

Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”) today announced its financial results for the second quarte...

Are there any upcoming catalysts (e.g., conference presentations, additional product launches, or FDA meetings) that could move the stock? What impact could this news have on Alpha Cognition’s stock price in the short term (intraday) and medium term (weeks to months)? How does the sentiment score of 70 align with the overall market perception of the stock?

Earnings

22 days ago

Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview

VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today annou...

Are there any notable changes in insider holdings or recent insider trading activity around the earnings release? Did the company provide any updates on risk factors, such as clinical trial delays, regulatory setbacks, or competition? What is the expected impact on the stock price after the earnings release and management commentary?

Earnings

about 1 month ago